The Japanese biotech behind Eli Lilly’s new blockbuster obesity pill believes it could be used with an anti-muscle wasting drug it has developed to create a new standard of patient care for weight ...

Tirzepatide is the first dual-target therapy that activates both GIP and GLP-1 receptors, helping manage blood sugar levels ...

Senator Gallego supports the bipartisan Treat and Reduce Obesity Act to improve Medicare's obesity-related services.

The build-up of dangerous fat in the organ is usually triggered by an unhealthy diet and sedentary lifestyle. Pictured: File ...

BENGALURU: Warning that one in three Indians could be obese by 2050 if unhealthy eating habits continue, Union Health ...

A new approach to tackling childhood obesity in South Australia is being applauded by one of the key policy-shapers at the ...

Analysis by Cancer Research UK of NHS data from the past 50 years revealed some positive news: deaths from cancer have ...

The US drugmaker sold ₹12.6 crore ($1.5 million) worth of the injections last month, according to market analysis firm ...

Union Health Minister Jagat Prakash Nadda on Saturday praised the innovative visual tools developed by the Food Safety and ...

Every Indian must make a vow to reduce salt and oil consumption by 10%, said Jagat Prakash Nadda, Union Minister for Health ...

Weight-loss drugs could stop hormone replacement therapy from working and increase the associated risks, guidance has warned.